top of page

NCI-2020-07076

Updated: Feb 21

A Phase 1 Study of SRF388 in Patients with Advanced Solid Tumors


This study aims to examine the safety and effectiveness of SRF388, a new drug, in treating patients with advanced solid tumors. People with advanced or metastatic solid tumors can participate.

metastatic: cancer that has spread from its original location or organ to other parts of the body.

For more information about the trial, click the link below:

Clinical Trial Site: Sinai


To see all available clinical trials click here.



 
 
 

Recent Posts

See All
NCI-2025-06021

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer (TRIPL) This is a research study exploring how combining radiation therapy with dual immune check

 
 
 
NCI-2024-05588

A Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants with Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in the AdjuvanT Setting (INSIGHT) The INSI

 
 
 
NCI-2022-08569

Randomized Phase III Trial of mFOLFIRINOX /- Nivolumab vs. FOLFOX /- Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma This randomized Phase III research

 
 
 

Comments

bottom of page